Cellular carboxypeptidases

Immunological Reviews

Volumn 161, Issue , 1998, Pages 129-141

  Skidgel, Randal A ^a   Erdös, Ervin G ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIDASE; ANGIOTENSIN I; ARGININE; BRADYKININ; CARBOXYPEPTIDASE; CARBOXYPEPTIDASE C; ENDOTHELIN; ENZYME INHIBITOR; FORMYLMETHIONYLLEUCYLPHENYLALANINE; LYSINE; PEPTIDE HORMONE; PROLINE; PROLINE CARBOXYPEPTIDASE; SERINE; SUBSTANCE P;

CARBOXY TERMINAL SEQUENCE; CELL SURFACE; ENDOCYTOSIS; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME RELEASE; HUMAN; LYSOSOME; MEMBRANE BINDING; PRIORITY JOURNAL; PROTEIN FAMILY; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CARBOXYPEPTIDASES; HUMANS;

EID: 0031886603     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-065X.1998.tb01577.x     Document Type: Review

References (88)

1. Salvesen GS, Dixit VM. Caspases: Intracellular signaling by proteolysis. Cell 1997;91:443-446.
2. Skidgel RA. Basic carboxypeptidases: regulators of peptide hormone activity. Trends Pharmacol Sci 1988;9:299-304.
3. Tan F, Morris PW, Skidgel RA, Erdös EG. Sequencing and cloning of human prolylcarboxypeptidase (angiotensinase C). Similarity to both serine carboxypeptidase and prolylendopeptidase families. J Biol Chem 1993;268:16631-16638.
4. Skidgel RA. Structure and function of mammalian zinc carboxypeptidases. In: Hooper NM, ed. Zinc Metalloproteases in Health and Disease. London: Taylor & Francis, Ltd. 1996. p. 241-283.
5. Waldschmidt-Leitz E, Ziegler F, Schäffner A, Weil L. Uber die Struktur der Protamine. I. Protaminase und die Produkte ihrer Enwirkung auf Clupein und Salmin. Z Physiol Chem 1931;197:219-236.
6. Folk JE, Gladner JA. Carboxypeptidase B.I. Purification of the zymogen and specificity of the enzyme. J Biol Chem 1958;231:379-391.
7. Erdös EG, Sloane EM. An enzyme in human blood plasma that inactivates bradykinin and kallidins. Biochem Pharmacol 1962;11:585-592.
8. Oshima G, Kato J, Erdös EG. Plasma carboxypeptidase N, subunits and characteristics. Arch Biochem Biophys 1975;170:132-138.
9. Plummer TH Jr, Hurwitz MY. Human plasma carboxypeptidase N. Isolation and characterization. J Biol Chem 1978;253:3907-3912.
10. Levin Y, Skidgel RA, Erdös EG. Isolation and characterization of the subunits of human plasma carboxypeptidase N (kininase I). Proc Natl Acad Sci USA 1982;79:4618-4622.
11. Skidgel RA, Davis RM, Erdös EG. Purification of a human urinary carboxypeptidase (kininase) distinct from carboxypeptidase A, B, or N. Anal Biochem 1984;140:520-531.
12. Skidgel RA, Johnson AR, Erdös EG. Hydrolysis of opioid hexapeptides by carboxypeptidase N. Presence of carboxypeptidase in cell membranes. Biochem Pharmacol 1984;33:3471-3478.
13. Johnson AR, Skidgel RA, Gafford JT, Erdös EG. Enzymes in placental microvilli: angiotensin I converting enzyme, angiotensinase A, carboxypeptidase, and neutral endopeptidase ("enkephalinase"). Peptides 1984;5:789-796.
14. Skidgel RA, Davis RM, Tan F. Human carboxypeptidase M: Purification and characterization of a membrane-bound carboxypeptidase that cleaves peptide hormones. J Biol Chem 1989;264:2236-2241.
15. Tan F, Chan SJ, Steiner DF, Schilling JW, Skidgel RA. Molecular cloning and sequencing of the cDNA for human membrane-bound carboxypeptidase M: Comparison with carboxypeptidases A, B, H and N. J Biol Chem 1989;264:13165-13170.
16. Skidgel RA, Anders RA, Deddish PA, Erdös EG. Carboxypeptidase (CP) M and H in small intestine. FASEB J 1991;5:1578 (Abstract).
17. Nagae A, et al. Carboxypeptidase M in brain and peripheral nerves. J Neurochem 1992;59:2201-2212.
18. McGwire GB, Tan F, Michel B, Rehli M, Skidgel RA. Identification of a membrane-bound carboxypeptidase as the mammalian homolog of duck gp180, a hepatitis B-virus binding protein. Life Sci 1997;60:715-724.
19. Song L, Fricker LD. Purification and characterization of carboxypeptidase D, a novel carboxypeptidase E-like enzyme, from bovine pituitary. J Biol Chem 1995;270:25007-25013.
20. Kuroki K, Eng F, Ishikawa T, Turck C, Harada F, Ganem D. gp180, a host cell glycoprotein that binds duck hepatitis B virus particles, is encoded by a member of the carboxypeptidase gene family. J Biol Chem 1995;270:15022-15028.
21. Xin X, et al. Cloning and sequence analysis of cDNA encoding rat carboxypeptidase D. DNA Cell Biol 1997;16:897-909.
22. Tan F, Rehli M, Krause SW, Skidgel RA. The sequence of human carboxypeptidase D reveals it to be a member of the regulatory carboxypeptidase family with three tandem active site domains. Biochem J 1997;327:81-87.
23. He G-P, Muise A, Li AW, Ro H-S. A eukaryotic transcriptional repressor with carboxypeptidase activity. Nature 1995;378:92-96
24. Song L, Fricker LD. Cloning and expression of human carboxypeptidase Z, a novel metallocarboxypeptidase. J Biol Chem 1997;272:10543-10550.
25. Yang HYT, Erdös EG, Chiang TS. New enzymatic route for the inactivation of angiotensin. Nature 1968;218:1224-1226.
26. Kumamoto K, Stewart TA, Johnson AR, Erdos EG. Prolylcarboxypeptidase (angiotensinase C) in human cultured cells. J Clin Invest 1981;67:210-215.
27. Skidgel RA, Wickstrom E, Kumamoto K. Erdös EG. Rapid radioassay for prolylcarboxypeptidase (angiotensinase C). Anal Biochem 1981;118:113-119.
28. Jackman HL, et al. Plasma membrane-bound and lysosomal peptidases in human alveolar macrophages. Am J Respir Cell Mol Biol 1995;13:196-204.
29. Jackman HL, et al. A peptidase in human platelets that deamidates tachykinins: Probable identity with the lysosomal "protective protein." J Biol Chem 1990;265:11265-11272.
30. Galjart NJ, et al. Expression of cDNA encoding the human "protective protein" associated with lysosomal β-galactosidase and neuraminidase: Homology to yeast proteases. Cell 1988;54:755-764.
31. D'Azzo A, Hoogeveen A, Reuser AJJ, Robinson D, Galjaard H. Molecular defect in combined β-galactosidase and neuraminidase deficiency in man. Proc Natl Acad Sci USA 1982;79:4535-4539.
32. Hanna WL, Turbov JM, Jackman HL, Tan F, Froelich CJ. Dominant chymotrypsin-like esterase activity in human lymphocyte granules is mediated by the serine carboxypeptidase called cathepsin A-like protective protein. J Immunol 1994;153:4663-4672.
33. Deddish PA, Skidgel RA, Kriho VB, Li X-Y, Becker RP, Erdös EG. Carboxypeptidase M in cultured Madin-Darby canine kidney (MDCK) cells. Evidence that carboxypeptidase M has a phosphatidylinositol glycan anchor. J Biol Chem 1990;265:15083-15089.
34. Tan F, Deddish PA, Skidgel RA. Human carboxypeptidase M. In: Barrett AJ, ed. Methods in Enzymology. Vol 248: Proteolytic enzymes, part E; Aspartic, metallo and other peptidases. Orlando: Academic Press; 1995. p. 663-675.
35. Skidgel RA, McGwire GB, Li X-Y. Membrane anchoring and release of carboxypeptidase M: Implications for extracellular hydrolysis of peptide hormones. Immunopharmacology 1996;32:48-52.
36. Kas K, Schoenmakers EFPM, Van de Ven WJM. Physical map location of the human carboxypeptidase M gene (CPM) distal to D12S375 and proximal to D12S8 at chromosome 12q15. Genomics 1995;30:403-405.
37. Song L, Fricker LD. Tissue distribution and characterization of soluble and membrane-bound forms of metallocarboxypeptidase D. J Biol Chem 1996;271:28884-28889.
38. Skidgel RA, Erdös EG. Biochemistry of angiotensin converting enzyme. In: Robertson JIS, Nicholls MG, eds. The Renin Angiotensin System. Vol 1. London: Gower Medical Publishing;1993. p.10.1-10.10.
39. Chartrain NA, et al. Molecular cloning, structure, and chromosomal localization of the human inducible nitric oxide synthase gene. J Biol Chem 1994;269:6765-6772.
40. Yang HYT, Erdös EG, Chiang TS, Jenssen TA, Rodgers JG. Characteristics of an enzyme that inactivates angiotensin II (angiotensinase C). Biochem Pharmacol 1970;19:1201-1211.
41. Odya CE, Marinkovic D, Hammon KJ, Stewart TA, Erdös EG. Purification and properties of prolylcarboxypeptidase (angiotensinase C) from human kidney. J Biol Chem 1978;253:5927-5931.
42. URL=http://inhouse.ncbi.nlm.nih.gov/cgi-bin/UniGene/clust?ORG=Hs&CID= 75693
43. Bonten EJ, Galjart NJ, Willemsen R, Usmany M, Vlak JM, d'Azzo A. Lysosomal protective protein/cathepsin A. Role of the "linker" domain in catalytic activation. J Biol Chem 1995;270:26441-26445.
44. van der Horst GTJ, Galjart NJ, d'Azzo A, Galjaard H, Verheijen FW. Identification and in vitro reconstitution of lysosomal neuraminidase from human placenta. J Biol Chem 1989;264:1317-1322.
45. Potier M, Michaud L, Tranchemontagne J, Thauvette L. Structure of the lysosomal neuraminidase-β-galactosidase-carboxypeptidase multienzymic complex. Biochem J 1990;267:197-202.
46. Wiegant J, Galjart NJ, Raap AK, d'Azzo A. The gene encoding human protective protein (PPGB) is on chromosome 20. Genomics 1991;10:345-349.
47. 2+ activation and inhibitor binding of carboxypeptidase M at low pH. Similarity to carboxypeptidase H (enkephalin convertase). Biochem J 1989;261:289-291.
48. Skidgel RA. Assays for arginine/lysine carboxypeptidases: carboxypeptidase H (E; enkephalin convertase);M and N. In: Conn PM, ed. Methods in Neurosciences: Peptide Technology. Vol 6. Orlando: Academic Press;1991. p. 373-385.
49. Plummer TH Jr, Ryan TJ. A potent mercapto bi-product analogue inhibitor for human carboxypeptidase N. Biochem Biophys Res Commun 1981;98: 448-454.
50. 53]EGF by carboxypeptidase M. J Biol Chem 1995;270:17154-17158.
51. Jackman HL, Morris PW, Deddish PA, Skidgel RA, Erdös EG. Inactivation of endothelin I by deamidase (lysosomal protective protein). J Biol Chem 1992;267:2872-2875.
52. Jackman HL, Morris PW, Rabito SF, Johansson GB, Erdös EG. Inactivation of endothelin 1 by an enzyme of the vascular endothelial cells. Hypertension 1993;21:925-928.
53. Deng Y, Martin LL, DelGrande D, Jeng AY. A soluble protease identified from rat kidney degrades endothelin-1 but not proendothelin-1. J Biochem 1992;112:168-172.
54. Deng AY, Martin LL, Balwierczak JL, Jeng AY. Purification and characterization of an endothelin degradation enzyme from rat kidney. J Biochem 1994;115:120-125.
55. Sirviö M-L, Saijonmaa O, Metsärinne K, Fyhrquist F. Degradation of endothelin-1 by extracts of rat lung, kidney, and liver. Regul Pept 1995;55:219-225.
56. Itoh K, Kase R, Shimmoto M, Satake A, Sakuraba H, Suzuki Y. Protective protein as an endogenous endothelin degradation enzyme in human tissues. J Biol Chem 1995;270:515-518.
57. Kuroki K, Cheung R, Marion PL, Ganem D. A cell surface protein that binds avian hepatitis B virus particles. J Virol 1994;68:2091-2096.
58. Nagae A, Abe M, Becker RP, Deddish PA, Skidgel RA, Erdös EG. High concentration of carboxypeptidase M in lungs: Presence of the enzyme in alveolar type I cells. Am J Respir Cell Mol Biol 1993;9:221-229.
59. Dragovic T, Schraufnagel DE, Becker RP, Sekosan M, Votta-Velis EG, Erdös EG. Carboxypeptidase M activity is increased in bronchoalveolar lavage in human lung disease. Am J Respir Crit Care Med 1995;152: 760-764.
60. de Saint-Vis B, et al. Distribution of carboxypeptidase-M on lymphoid and myeloid cells parallels the other zinc-dependent proteases CD10 and CD13. Blood 1995;86:1098-1105.
61. Rehli M, Krause SW, Kreutz M, Andreesen R. Carboxypeptidase M is identical to the MAX.1 antigen and its expression is associated with monocyte to macrophage differentiation. J Biol Chem 1995;270:15644-15649.
62. Miller JJ, Changaris DG, Levy RS. Angiotensin carboxypeptidase activity in urine from normal subjects and patients with kidney damage. Life Sci 1991;48:1529-1535.
63. Skidgel RA, Jackman HL, Erdös EG. Metabolism of substance P and bradykinin by human neutrophils. Biochem Pharmacol 1991;41:1335-1344.
64. Hinek A. Biological roles of the non-integrin elastin/laminin receptor. Biol Chem 1996;377:471-480.
65. Galjart NJ, Gillemans N, Meijer D. d'Azzo A. Mouse "protective protein". cDNA cloning, sequence comparison, and expression. J Biol Chem 1990;265:4678-4684.
66. http://inhouse.ncbi.nlm.nih.gov/cgi-bin/UniGene/clust?ORG=Hs&CID=985
67. Carretero OA, Scicli AG. Kinins, paracrine hormones, in the regulation of blood flow, renal function, and blood pressure. In: Laragh JH, Brenner BM, Kaplan NM, eds. Endocrine Mechanisms in Hypertension. New York: Raven Press;1989. p. 219-239.
68. Skidgel RA. Bradykinin degrading enzymes: Structure, function, distribution, and potential roles in cardiovascular pharmacology. J Cardiovasc Pharmacol 1992;20 (Suppl 9): S4-S9.
69. Bhoola KD, Figueroa CD, Worthy K. Bioregulation of kinins: Kallikreins, kininogens, and kininases. Pharmacol Rev 1992;44:1-80.
70. Crecelius DM, Stewart JM, Vavrek RJ, Balasubramaniam TM, Baenziger NL. Interaction of bradykinin (BK) with receptors on human lung fibroblasts. Fed Proc 1986;45:454.
71. 9-bradykinin: possible role of interleukin-1. Br J Pharmacol 1991;103:1057-1066.
72. 9-bradykinin (BK). FASEB J 1988;2:1145 (Abstract).
73. Tiffany CW, Burch RM. Bradykinin stimulates tumor necrosis factor and interleukin-1 release from macrophages. FEBS Lett 1989;247:189-192.
74. MacFadden RG, Vickers K. Bradykinin stimulates lymphocyte movement in vitro. FASEB J 1988;2:1179 (Abstract).
75. Marceau F, Lundberg C, Hugli TE. Effects of the anaphylatoxins on circulation. Immunopharmacology 1987;14:67-84.
76. desarg retains basophil-activating properties. Eur J Immunol 1994;24:1583-1589.
77. Fahnestock M. Structure and biosynthesis of nerve growth factor. Curr Top Microbiol Immunol 1991;165: 1-26.
78. Server AC, Sutter A, Shooter EM. Modification of the epidermal growth factor affecting the stability of its high molecular weight complex. J Biol Chem 1976;251:1188-1196.
79. Erdös EG, Wagner BA, Harbury CB, Painter RG, Skidgel RA, Fa X-G. Down-regulation and inactivation of neutral endopeptidase 24.11 (enkephalinase) in human neutrophils. J Biol Chem 1989;264:14519-14523.
80. 1 MF-2 smooth muscle cells process internalized bradykinin via multiple degradative pathways. J Biol Chem 1992;267:303-309.
81. Yamashiro DJ, Maxfield FR. Regulation of endocytic process by pH. Trends Pharmacol Sci 1988;9:190-194.
82. Jones DA, et al. Metabolism of the anticancer peptide:H-Arg-D-Trp-NmePhe-D-Trp-Leu-Met-NHZ. Peptides 1995;16:777-783.
83. 8]-substance P (6-11) by a small cell lung cancer cell line (H69). Biochem Pharmacol 1995;49:1709-1712.
84. Duff JL, Marrero MB, Paxton WG, Schleifer B, Bernstein KE, Berk BC. Angiotensin II signal transduction and the mitogen-activated protein kinase pathway. Cardiovasc Res 1995;30:511-517.
85. Mahon JM, Carr RD, Nicol AK, Henderson IW. Angiotensin(1-7) is an antagonist at the type 1 angiotensin II receptor. J Hypertens 1994;12:1377-1381.
86. Li P, Chappell MC, Ferrario CM, Brosnihan KB. Angiotensin-(1-7) augments bradykinin-induced vasodilation by competing with ACE and releasing nitric oxide. Hypertension 1997;29(Pt 2):394-400.
87. Deddish PA, Marcic B, Jackman HL, Wang H-Z, Skidgel RA, Erdös EG. N-domain specific substrate and C-domain inhibitors of angiotensin converting enzyme: Angiotensin-(1-7) and keto-ACE. Hypertension (In press).
88. Sorrells K, Erdös EG. Prolylcarboxypeptidase in biological fluids. In: Hinshaw LB, Cox BG, eds. The Fundamental Mechanisms of Shock. New York: Plenum Publishing Co. 1972. p. 393-397.